UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055805
Receipt number R000063781
Scientific Title A randomized, comparative study of adhesion to skin between two firm dressings in healthy participants
Date of disclosure of the study information 2024/10/11
Last modified on 2024/10/11 11:18:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of adhesion to skin for film dressings

Acronym

A study of adhesion to skin for film dressings

Scientific Title

A randomized, comparative study of adhesion to skin between two firm dressings in healthy participants

Scientific Title:Acronym

A randomized, comparative study of adhesion to skin between two firm dressings in healthy participants

Region

Japan


Condition

Condition

Healthy participants

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the adhesion of two film dressings on the forearm skin of healthy participants over a 4-day application period.

Basic objectives2

Others

Basic objectives -Others

Adhesion to the skin

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adhesion to the skin after 4 days of dermal application

Key secondary outcomes

Adhesion, itchiness, pain, skin maceration, adhesive residue, skin reaction


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Right forearm: Dressing A
Left forearm: Dressing B

Interventions/Control_2

Right forearm: Dressing B
Left forearm: Dressing A

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

49 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Japanese female and male participants who were aged 20 to 49 years
2. Healthy aprticipants who has no history of outpatient visits or medication for disease treatment
3. Participants who have healthy skin
4. Participats who are able to provide informed consent
5. Participats who are able to shave forearm hair with a T-shaped razor, if necessary.

Key exclusion criteria

1. Participants who have a history of previous treatment applied to the skin, particularly within the previous 2 weeks
2. Participants who have a history of anaphylactoid symptoms
3. Participants who have a history of hypersensitivity symptoms when applying a skin dressing or bandage
4. Participants who have a current history of atopic dermatitis
5. Participants who have a skin symptoms such as wounds or eczema on the forearm
6. Participants who have excessive hairiness on the forearm.

Target sample size

26


Research contact person

Name of lead principal investigator

1st name Takemasa
Middle name
Last name Kokubo

Organization

NICHIBAN CO., LTD.

Division name

Quality Assurance

Zip code

112-8663

Address

2-3-3 SEKIGUCHI, BUNKYO-KU, TOKYO, 112-8663, JAPAN

TEL

03-5978-5089

Email

t-kokubo@nichiban.co.jp


Public contact

Name of contact person

1st name Shiori
Middle name
Last name Sakurai

Organization

NICHIBAN CO., LTD.

Division name

Medical Regulatory Affairs

Zip code

112-8663

Address

2-3-3 SEKIGUCHI, BUNKYO-KU, TOKYO, 112-8663, JAPAN

TEL

03-5978-5089

Homepage URL


Email

shio-murayama@nichiban.co.jp


Sponsor or person

Institute

SOUKEN Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

NICHIBAN CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

26

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 09 Month 28 Day

Date of IRB

2023 Year 09 Month 28 Day

Anticipated trial start date

2023 Year 10 Month 18 Day

Last follow-up date

2023 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 11 Day

Last modified on

2024 Year 10 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063781